ArticleBMC medical ethics2026
On the "tightrope" of retail: reflections on ethical dilemmas faced by the pharmaceutical professionals in community pharmacies.
Article in BMC medical ethics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Ethical perspectives of Brazilian community pharmacists: a pilot study.BMC medical ethics · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
introductionBrazil has one of the largest drug retail markets globally and more than three times the recommended number of pharmacies per inhabitant. In this scenario, pharmacists have ethical dilemmas that lead to poor credibility among the population. Due to the lack of studies that address the view of stakeholders who are essential in delineating the code of conduct in this scenario, they had to be heard so that business imperatives could be better understood. This study aimed to understand the perceptions of drug retail stakeholders regarding the influences, causes, and strategies needed to minimize ethical dilemmas in pharmacy practice.
methodsNineteen semi-structured interviews were conducted online, transcribed, and analyzed by content analysis. Word clouds and themes were created, and we compared the opinions reported by the groups of managers and mentors.
resultsThe results of the perceptions were classified into the following themes: (a) Industry Enticement-main consequence, (b) "Push therapy" and strategies to minimize these dilemmas, (c) Assimilating that selling is not unethical, (d) Compliance, (e) Collective goals, (f) Generating profits through services. The poor diffusion of compliance programs and the fragile autonomy of the pharmacist keep the profession on the "tightrope". Therefore, investing more in services and state actions for patient safety rather than in products could balance this scenario.
conclusionThe ethical discourse of stakeholders remains ideological and is not consolidated in pharmacy practice. Accelerating market regulation through compliance and effective state action, as well as monetizing pharmaceutical services, could create a more ethical environment for the sector.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.